(Q46856627)

English

Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study

scientific article published on 11 December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18071341

Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18071341

0 references

polycystic ovary syndrome

1 reference

based on heuristic

inferred from title

(RS)-sibutramine

1 reference

based on heuristic

inferred from title

polycystic ovary

1 reference

based on heuristic

inferred from title

Evanthia Diamanti-Kandarakis

2

object named as

Diamanti-Kandarakis E

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18071341

author name string

Florakis D

1

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18071341

Katsikis I

3

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18071341

Nassis GP

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18071341

Karkanaki A

5

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18071341

Georgopoulos N

6

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18071341

Panidis D

7

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18071341

language of work or name

0 references

publication date

11 December 2007

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18071341

International Journal of Obesity

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18071341

32

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18071341

4

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18071341

692-699

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18071341

https://scigraph.springernature.com/pub.10.1038/sj.ijo.0803777

0 references

A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Polycystic ovary syndrome: syndrome XX?

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Prevalence of impaired glucose tolerance and diabetes in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Prevalence and predictors of risk for type 2 diabetes mellitus and impaired glucose tolerance in polycystic ovary syndrome: a prospective, controlled study in 254 affected women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Coronary Heart Disease Risk Factors in Women With Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Mortality of women with polycystic ovary syndrome at long-term follow-up

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Overweight women with polycystic ovary syndrome have evidence of subclinical cardiovascular disease

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Restoration of reproductive potential by lifestyle modification in obese polycystic ovary syndrome: role of insulin sensitivity and luteinizing hormone.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Restored insulin sensitivity but persistently increased early insulin secretion after weight loss in obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Increased insulin sensitivity and fibrinolytic capacity after dietary intervention in obese women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Weight loss in obese infertile women results in improvement in reproductive outcome for all forms of fertility treatment

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Dietary composition in restoring reproductive and metabolic physiology in overweight women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

The role of lifestyle modification in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Improvement in endocrine and ovarian function during dietary treatment of obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Effect of long-term treatment with metformin added to hypocaloric diet on body composition, fat distribution, and androgen and insulin levels in abdominally obese women with and without the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Evaluation of assays available to measure free testosterone

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Post-prandial thermogenesis and insulin sensitivity in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Effects of sibutramine on abdominal fat mass, insulin resistance and blood pressure in obese hypertensive patients.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

A randomized trial of the effects of two types of short-term hypocaloric diets on weight loss in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Sibutramine in the treatment of obesity in type 2 diabetic patients and in nondiabetic subjects

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Sibutramine enhances insulin sensitivity ameliorating metabolic parameters in a double-blind, randomized, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Polycystic ovary syndrome and hyperprolactinemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatography-mass spectrometry in sera from 116 men, women, and children

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Position statement: Utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

21 January 2018

Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

7 January 2021

based on heuristic

inferred from DOI database lookup

Polycystic ovary syndrome and risk for myocardial infarction. Evaluated from a risk factor model based on a prospective population study of women

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

7 January 2021

based on heuristic

inferred from DOI database lookup

Differences in clinical and endocrine features between obese and non-obese subjects with polycystic ovary syndrome: an analysis of 263 consecutive cases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

7 January 2021

based on heuristic

inferred from DOI database lookup

Weight loss is associated with correction of gonadotropin and sex steroid abnormalities in the obese anovulatory female.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

7 January 2021

based on heuristic

inferred from DOI database lookup

Thermogenic effects of sibutramine in humans

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

7 January 2021

based on heuristic

inferred from DOI database lookup

The cerebrospinal fluid/serum leptin ratio during pharmacological therapy for obesity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

7 January 2021

based on heuristic

inferred from DOI database lookup

Influence of Sibutramine on blood pressure: evidence from placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized, double-blind, placebo-controlled, multicenter study of sibutramine in obese hypertensive patients

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of sibutramine on weight loss and blood pressure: a meta-analysis of controlled trials

1 reference

https://api.crossref.org/works/10.1038%2FSJ.IJO.0803777

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/SJ.IJO.0803777

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18071341

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 December 2017

http://europepmc.org/abstract/MED/18071341

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46856627&oldid=2135107039"